أعرض تسجيلة المادة بشكل مبسط
dc.creator |
Augurzky, Boris |
|
dc.creator |
Göhlmann, Silja |
|
dc.creator |
Greß, Stefan |
|
dc.creator |
Wasem, Jürgen |
|
dc.date |
2006 |
|
dc.date.accessioned |
2013-10-16T07:00:44Z |
|
dc.date.available |
2013-10-16T07:00:44Z |
|
dc.date.issued |
2013-10-16 |
|
dc.identifier |
http://hdl.handle.net/10419/18597 |
|
dc.identifier |
ppn:51635700X |
|
dc.identifier.uri |
http://koha.mediu.edu.my:8181/xmlui/handle/10419/18597 |
|
dc.description |
This paper examines effects of reference pricing for prescription drugs in German social health insurance based on econometric panel data methods. We analyze the effect on ex-factory prices. Moreover, we investigate whether manufacturers adapt prices of their products not subject to reference pricing as a consequence of changes in reference prices of their products subject to reference pricing.We use a large panel data set of nearly all German prescription drugs on a monthly basis between October 1994 and July 2005. Altogether, the data comprise almost 4 million observations. They provide information on ex-factory prices, reference prices, manufacturers, type of prescription drug, and market entries and exits. Our results show that there is no full price adjustment:A 1%-change in reference prices leads to a 0.3%-change in market prices. Price adjustment, however, is fast, it mostly happens in the first month. Furthermore, the first introduction of a reference price reduces market prices of the affected products by approximately 14%. Finally, we observe a significant time effect which is positive in the market without reference prices and negative in that with reference price. |
|
dc.language |
eng |
|
dc.publisher |
|
|
dc.relation |
RWI Discussion Papers 46 |
|
dc.rights |
http://www.econstor.eu/dspace/Nutzungsbedingungen |
|
dc.subject |
I11 |
|
dc.subject |
I18 |
|
dc.subject |
ddc:330 |
|
dc.subject |
Price elasticity |
|
dc.subject |
temporal development |
|
dc.subject |
fixed effects model |
|
dc.title |
The effects of reference pricing on ex-factory prices of Rx drugs in Germany : a panel data approach |
|
dc.type |
doc-type:workingPaper |
|
الملفات في هذه المادة
لا توجد أي ملفات مرتبطة بهذه المادة.
|
هذه المادة تبدو في المجموعات التالية:
أعرض تسجيلة المادة بشكل مبسط